Ropes & Gray Represents Abilita Therapeutics in Orion Research Collaboration to Develop Next-Generation Antibody Therapeutics
December 21, 2024
December 21, 2024
BOSTON, Massachusetts, Dec. 21 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Abilita Therapeutics in a global licensing and multi-target research collaboration with Finnish Orion Corporation (Orion) focused on discovery, development and commercialization of next-generation antibody therapeutics in oncology and pain.
The companies will use Abilita's pioneering antibody discovery platform to unlock challenging multi-span membrane . . .
Ropes & Gray advised Abilita Therapeutics in a global licensing and multi-target research collaboration with Finnish Orion Corporation (Orion) focused on discovery, development and commercialization of next-generation antibody therapeutics in oncology and pain.
The companies will use Abilita's pioneering antibody discovery platform to unlock challenging multi-span membrane . . .